Search | Page 8 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Mechanisms and Clinical Implications of Thrombosis in Paroxysmal Nocturnal Hemoglobinuria

    ... (PNH) is a rare acquired disease characterized by a clone of blood cells lacking glycosyl inostitol phosphatidyl (GPI) anchored ...

    Research Article last updated 11/21/2011 - 3:08pm.

  2. SNP array-based karyotyping: differences and similarities between aplastic anemia and hypocellular myelodysplastic syndromes.

    ... syndromes (MDS) a single hematopoietic clone often characterized by chromosomal aberrations expands and ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression.

    ... BM samples. Results TP53 mutations with a median clone size of 11% (range, 1% to 54%) were detected in 10 patients (18%) ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Demonstration of additional benefit in adding lenalidomide to azacitidine in patients with higher-risk myelodysplastic syndromes.

    ... bone marrow microenvironment and the malignant clone . A recent Phase I trial testing the lenalidomide and azacitidine ...

    Research Article last updated 10/11/2011 - 5:58pm.

  5. Lenalidomide for treatment of myelodysplastic syndromes: current status and future directions.

    ... In del(5q) patients, lenalidomide suppresses the clone by inhibiting the nuclear sequestration of the haplodeficient cell ...

    Research Article last updated 10/11/2011 - 5:58pm.

  6. Hypomethylating agents in myelodysplastic syndromes changing the inevitable: the value of azacitidine as maintenance therapy, effects on transfusion and combination with other agents.

    ... has a progressively cumulative effect on the MDS clone and support the value of maintenance therapy. Prolonged survival was ...

    Research Article last updated 10/11/2011 - 5:58pm.

  7. Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia

    ... of a paroxysmal nocturnal hemoglobinuria clone (P=0.01) and a pretreatment absolute reticulocyte count ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine.

    ... a glycosylphosphatidylinositol-anchor protein-deficient clone was detected in 83 (40%) patients pre-treatment, and the median clone size was 9.7% (interquartile range 3.5-29). In patients without a ...

    Research Article last updated 10/11/2011 - 5:58pm.

  9. Loss of expression of neutrophil proteinase-3: a contributory factor in thrombotic risk in paroxysmal nocturnal hemoglobinuria.

    ... with a decrease in plasma proteinase 3 levels, clone size and history of thrombosis . In addition, we found that ...

    Research Article last updated 10/11/2011 - 5:58pm.

  10. Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia.

    ... Twenty-seven patients with AA and a detectable PNH clone were monitored for a median of 5.7 years (range1.5 to 11.5 years). ... The erythrocyte and granulocyte PNH clone sizes were measured using flow cytometry and analyzed via CellQuest ...

    Research Article last updated 10/11/2011 - 5:58pm.